Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford cancer symptoms paper is the second most read paper in the British Journal of General Practice in 2021

The team identified new symptoms that could help doctors diagnose pancreatic cancer.

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

New study highlights importance of early diagnosis for ovarian cancer survival

Analysis of data from the Million Women Study demonstrates the association between stage at diagnosis and survival.

Study sheds new light on the association between an infectious bacterium and gastric cancer in China

Helicobacter pylori infection increases the risk of both cardia gastric cancer and non-cardia gastric cancer in the China Kadoorie Biobank.

New partnership for Oxford early cancer detection research spin-out

Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including the work of OxCODE members.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

The University of Oxford will lead a £2m national cancer prevention trial in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

Fewer cases of children’s cancer picked up during the COVID pandemic

An Oxford study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic, but cancer diagnosis in children following admission to intensive care was higher.

Datasets used to train AI to detect skin cancer are insufficient and lacking in pictures of darker skin

Work by researchers at Oxford University Hospitals has highlighted how the images and accompanying data available for training artificial intelligence (AI) to spot skin cancer are insufficient and include very few images of darker skin.

New symptoms identified that could help doctors diagnose pancreatic cancer

Dr Weiqi Liao and Professor Julia Hippisley-Cox have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms.

Identifying early clinical features of myeloma in primary care

Research by Dr Karthik Ramasamy into the earlier recognition of myeloma symptoms in primary care aims to accelerate myeloma diagnosis.

Impact award for publication on ovarian cancer

A paper led by Dr Zhiyuan Hu from Professor Ahmed Ahmed’s lab has won the Columbia Hospital for Women Research Foundation’s 2020-2021 prize for impact.

Pancreatic cancer early detection funds awarded to OxCODE researchers

Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.

OxCODE researchers at the Early Detection of Cancer Conference 2021

Oxford’s early detection research was featured at this annual event.

Turing Fellowships for four OxCODE members

Hashem Koohy, Rafael Perera, Benjamin Schuster-Böckler and Clare Verrill will join the Turing network for 2021-2022 to further their research in cancer big data.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri™ in suspected cancer patients.

Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection

Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.

OxCODE funds three early detection projects

Congratulations to Alistair Easton, Siim Pauklin, Susie Shapiro and their collaborators who have been awarded funding in the second round of the OxCODE Funding Scheme.

Oxford spin-out partners with Johnson & Johnson to improve lung cancer survival rates

Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.

New network Oxford Cancer launches

OxCODE is working under the umbrella of a new pan-divisional initiative at the University of Oxford that brings together the collective force of cancer research, outreach and care that happen across the city of Oxford.

Load More